Genetically engineered therapy helped to achieve remission of a patient with psoriasis in Ryazan
In the Ryazan skin and venereological dispensary told about the successful case of using genetically engineered biological therapy

In the Ryazan skin and venereological dispensary told about the successful case of the use of genetically engineered biological therapy. The modern method allowed to achieve stable clinical remission in a patient who suffered from a severe form of psoriasis for more than 15 years.
The disease was accompanied by painful itching, extensive rashes and damage to the nail plates. Standard treatment regimens, which included repeated hospitalization, basic therapy, physiotherapy and external remedies, eventually lost their effectiveness - new psoriatic elements continued to appear on the skin.
Due to the torpidity (stability) of the course of dermatosis, the medical commission decided to transfer the 38-year-old man to a genetically engineered drug. After the necessary examination, the man was initiated subcutaneous therapy.
Against the background of treatment, the rash began to regress, the condition of the nail plates normalized. The patient tolerates therapy well and currently continues to receive the drug according to the scheme, being in clinical remission.
“The dispensary pays special attention to an individual approach to each patient, the selection of effective treatment tactics and the introduction of modern medical technologies that allow achieving positive results even in complex clinical cases,” the press service of the OKKVD said.



